AntineoplasticsDrug resistance and lack of efficacy: 6 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1906卷 / 1期

关键词：

D O I：

10.1007/s40278-022-14951-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：61 / 61

相关论文

共 50 条

[31] ApixabanMajor bleeding and lack of efficacy: 6 case reports
Reactions Weekly, 2022, 1923 (1) : 68 - 68
[32] Carbamazepine/phenytoinHyponatraemia and lack of efficacy: 6 case reports
Reactions Weekly, 2022, 1918 (1) : 125 - 125
[33] Dimethyl fumarateLymphopenia and lack of efficacy: 6 case reports
Reactions Weekly, 2022, 1902 (1) : 177 - 177
[34] TacrolimusPericardial effusion and lack of efficacy: 6 case reports
Reactions Weekly, 2025, 2046 (1) : 374 - 374
[35] Antineoplastics/steroidsRash and lack of efficacy: 6 case reports
Reactions Weekly, 2022, 1935 (1) : 85 - 85
[36] Alemtuzumab/cladribineLymphopenia and lack of efficacy : 6 case reports
Reactions Weekly, 2022, 1930 (1) : 26 - 27
[37] Multiple drugsDiarrhoea and lack of efficacy: 6 case reports
Reactions Weekly, 2023, 1963 (1) : 359 - 359
[38] NelarabineVarious toxicities and lack of efficacy: 6 case reports
Reactions Weekly, 2023, 1945 (1) : 412 - 412
[39] Multiple drugsAnaphylaxis and lack of efficacy: 6 case reports
Reactions Weekly, 2022, 1929 (1) : 423 - 424
[40] AntineoplasticsVarious toxicities and lack of efficacy : 6 case reports
Reactions Weekly, 2024, 2018 (1) : 60 - 60

← 1 2 3 4 5 →